Skip to Content
You are currently on the new version of our website. Access the old version .

12 Results Found

  • Article
  • Open Access
1 Citations
4,908 Views
16 Pages

The objective of this study was to determine the physicochemical in-use stability of recently approved Thiotepa Riemser concentrate in the original vial and diluted ready-to-administer (RTA) infusion solutions in prefilled glucose 5% and 0.9% NaCl po...

(This article belongs to the Section Biopharmaceutics)
  • Article
  • Open Access
5 Citations
4,701 Views
11 Pages

Thiotepa, Busulfan, Cyclophosphamide: Effective but Toxic Conditioning Regimen Prior to Autologous Hematopoietic Stem Cell Transplantation in Central Nervous System Lymphoma

  • Lebon Delphine,
  • Debureaux Pierre-Edouard,
  • Royer Bruno,
  • Gruson Bérengère and ,
  • Joris Magalie,
  • Votte Patrick,
  • Marolleau Jean-Pierre and
  • Morel Pierre
  • + 3 authors+ 0 author

29 January 2023

In primary central nervous system lymphoma, two-year progression-free survival rates of up to 63 percent have been reported for first-line autologous stem cell transplantation after conditioning with the thiotepa busulfan cyclophosphamide regimen. Ho...

(This article belongs to the Topic Advances in Anti-Cancer Drugs)
  • Review
  • Open Access
11 Citations
7,367 Views
15 Pages

Diagnosis and Treatment Using Autologous Stem-Cell Transplantation in Primary Central Nervous System Lymphoma: A Systematic Review

  • Sara Steffanoni,
  • Teresa Calimeri,
  • Sarah Marktel,
  • Rosamaria Nitti and ,
  • Marco Foppoli and
  • Andrés J. M. Ferreri
  • + 1 author+ 0 author

15 January 2023

Background: Consolidation therapy has improved the outcome of newly diagnosed PCNSL patients. Whole-brain radiotherapy (WBRT) was the first consolidation strategy used and represented the gold standard for many years, but at the expense of a high ris...

(This article belongs to the Special Issue Primary CNS Lymphomas: Diagnosis and Treatment)
  • Case Report
  • Open Access
375 Views
14 Pages

Berubicin Substituted for Cytarabine in a MATRix-Based Regimen for Isolated Central Nervous System Lymphoma: A Five-Patient Case Series from the BER-PUM Study

  • Sławomir Milczarek,
  • Oliwia Piotrowska,
  • Bartłomiej Baumert,
  • Ewa Borowiecka and ,
  • Krzysztof Sommerfeld,
  • Alina Hnatyszyn and
  • Bogusław Machaliński
  • + 2 authors+ 0 author

15 September 2026

Primary and isolated secondary central nervous system lymphomas are aggressive malignancies requiring effective central nervous system–directed therapy. Intensive high-dose methotrexate–based regimens may be difficult to deliver, particul...

(This article belongs to the Section Hematology)
  • Article
  • Open Access
15 Citations
3,510 Views
14 Pages

23 April 2022

High-dose chemotherapy with autologous stem cell transplantation (HCT-ASCT) is reportedly an effective treatment strategy in relapsed or refractory primary CNS lymphoma (r/r PCNSL); however, only selected patients are eligible for this treatment. We...

  • Case Report
  • Open Access
2 Citations
1 Views
2 Pages

Imatinib Mesylate Treatment for Platelet-Derived Growth Factor Receptor Alfa-Positive Choroid Plexus Carcinoma

  • Chihiro Kawakami,
  • Akiko Inoue,
  • Kimitaka Takitani,
  • Motomu Tsuji and ,
  • Kimiko Wakai and
  • Hiroshi Tamai
  • + 1 author+ 0 author

We herein report a female child with choroid plexus carcinoma treated with standard dose of imatinib at disease recurrence. This patient failed initial twice-surgical resections, central nervous system (CNS) irradiation, and adjuvant chemotherapies a...

  • Article
  • Open Access
6 Citations
1,715 Views
9 Pages

14 November 2012

Six murine tumors, including ascetic tumors HepA, EC, P388 leukemia, S180 and solid tumor S180, and Lewis lung carcinoma, were employed in this work. The free sialic acid concentrations in both blood and ascites were measured in tumor-bearing mice. T...

  • Article
  • Open Access
14 Citations
4,188 Views
12 Pages

Acute Hematological Toxicity during Cranio-Spinal Proton Therapy in Pediatric Brain Embryonal Tumors

  • Sabina Vennarini,
  • Giada Del Baldo,
  • Stefano Lorentini,
  • Riccardo Pertile and ,
  • Francesco Fabozzi,
  • Pietro Merli,
  • Giacomina Megaro,
  • Daniele Scartoni,
  • Andrea Carai and
  • Angela Mastronuzzi
  • + 8 authors+ 3 authors

24 March 2022

Background: Embryonal tumors represent a heterogeneous entity of brain tumors that need a multidisciplinary treatment including cranio-spinal irradiation (CSI), with a known impact on the acute toxicity. Proton therapy (PT) boasts a reduction in acut...

  • Article
  • Open Access
2 Citations
4,356 Views
11 Pages

Patient Reported and Clinical Outcomes after High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Primary Central Nervous System Lymphoma

  • Sina A. Beer,
  • Stefan Wirths,
  • Wichard Vogel,
  • Ghazaleh Tabatabai and ,
  • Ulrike Ernemann,
  • David A. Merle,
  • Wolfgang Bethge,
  • Robert Möhle and
  • Claudia Lengerke
  • + 4 authors+ 0 author

21 January 2023

Primary central nervous system lymphomas (PCNSL) are rare and associated with an adverse prognosis. High-dose chemotherapy followed by autologous stem cell transplantation (HDC/ASCT) improves progression free (PFS) and overall survival (OS) but neuro...

(This article belongs to the Section Cancer Therapy)
  • Review
  • Open Access
938 Views
15 Pages

Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis: Evolving Indications, Conditioning Strategies, and Outcomes

  • Caterina Alati,
  • Stefano Botti,
  • Francesca Cogliandro,
  • Martina Pitea and ,
  • Matteo Pacilli,
  • Gaetana Porto,
  • Giorgia Policastro,
  • Annalisa Sgarlata,
  • Maria Caterina Mico and
  • Massimo Martino
  • + 9 authors+ 4 authors

Background/Objectives: Myelofibrosis (MF) is a clonal myeloproliferative neoplasm driven by dysregulated JAK-STAT signaling, characterized by progressive marrow fibrosis, splenomegaly, constitutional symptoms, and increased risk of leukemic transform...

(This article belongs to the Special Issue Outcomes and Complications Post-Allogeneic Hematopoietic Cell Transplantation)
  • Article
  • Open Access
264 Views
12 Pages

Hematopoietic Cell Transplantation in Children with Sickle Cell Disease: A Single-Center Experience and Exploration of an Age Threshold for Post-Transplant Complications

  • Charlotte Nazon,
  • Chloé Gerber,
  • Alexandra Salmon,
  • Annie Kamdem and ,
  • Claire Pluchart,
  • Bruno Filhon,
  • Anne-Cécile Galoisy,
  • Françoise Bernaudin and
  • Catherine Paillard
  • + 4 authors+ 0 author

20 October 2026

Background/Objectives: Hematopoietic cell transplantation (HCT) is the only established curative option for sickle cell disease (SCD), yet the optimal timing in pediatric cohorts remains incompletely defined. Methods: We retrospectively analyzed all...

(This article belongs to the Section Hematology)
  • Article
  • Open Access
1 Citations
3,552 Views
15 Pages

The Value of Thin Layer Cytology in Cancer Patients’ Pericardial Effusions

  • Christos Lafaras,
  • Evdokia Mandala,
  • Kyranna Lafara,
  • Ioannis Kalafatis and ,
  • Thomas Achladas,
  • Vasiliki Koukoulitsa,
  • Chrysoula Gouta,
  • Theodora Tsiouda and
  • Soultana Skevoudi
  • + 4 authors+ 0 author

Objective: Early diagnosis and treatment of metastatic pericardial disease are crucial to prevent the life-threatening complication of cardiac tamponade. Thin Layer Cytology (TLC), a widely adopted technique in cytology, has gained significant accept...